F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
The Food and Drug Administration has approved Abraxane, which in a clinical trial prolonged the lives of patients by a little less than two months on ...
Shared via Google Currents
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
The Food and Drug Administration has approved Abraxane, which in a clinical trial prolonged the lives of patients by a little less than two months on ...
Shared via Google Currents
No comments:
Post a Comment